期刊文献+

shRNA结合^(131)I-免疫脂质体抑制胶质瘤细胞U251增殖的初步研究

A Preliminary Study about the Inhibition of U251 Cell Proliferation by Expressing shRNA Combined with ^(131)I-immune Liposome
下载PDF
导出
摘要 目的探索RNA干扰与^(131)I-免疫脂质体联用在胶质瘤疾病治疗中的潜在价值。方法在合成p GPU6-GFP-Neo-EGFRv III-shRNA表达载体的基础上,结合核素内放射性^(131)I免疫脂质体,进行细胞实验探索其对胶质瘤细胞U251增殖凋亡的影响。结果成功构建p GPU6-GFP-Neo-EGFRv III-shRNA载体;同时细胞实验结果显示,shRNA和^(131)I免疫脂质体联用有效抑制胶质瘤细胞U251增殖和促进其凋亡,抑制率达70%。结论 shRNA结合^(131)I免疫脂质体能高效地促凋亡和抑制细胞增殖,为其在胶质瘤治疗中的应用奠定了初步基础。 Objective To investigate the potential value of RNAi combined with ^131I-immune liposome in glioma treat- ment. Methods Structuring the vector harboring EGFRv III shRNA expression cassettes, used in cell experiments with ^131I-im- mune liposome, to study the effect on proliferation and apoptosis of U251 cells. Results shRNA combined with ^131I-immune lipo- some targeted to EGFRv III was able to effectively inhibit the proliferation and apoptosis of U251 cell. The inhibition rate was 70%. Conclusion shRNA combined with ^131I-immune liposome can efficiently promote apoptosis and inhibit cells proliferation, which laid a preliminary foundation for its application in the treatment of gliomas.
出处 《实用癌症杂志》 2016年第8期1219-1221,1224,共4页 The Practical Journal of Cancer
基金 上海市卫生与计划生育委员会青年基金项目(编号:20114y194)
关键词 神经胶质瘤 U251细胞 ^131I SHRNA RNA干扰 免疫脂质体 Gliomas U251 cell ^131I shRNA RNA interference Lmmune liposome
  • 相关文献

参考文献13

  • 1Paul I, Bhattacharya S, Chatterjee A, et al. Current Under- standing on EGFR and Wnt/13-Catenin Signaling in Glioma and Their Possible Crosstalk [ J ]. Genes Cancer, 2013,4 (11-12) :427-46.
  • 2Kornblithp PL, Wlker M. Chemotherapy for malignant glio- ma[ J]. J Neurosurg, 1988,68 ( 1 ) : 1-17.
  • 3Sontheimer E J, Carthew RW. Silence from within:endoge- nous siRNAs and miRNAs[ J ]. Cell,2005,122 ( 1 ) :9-12.
  • 4Uchino K, Ochiya T, Takeshita F. RNAi therapeutics and applications of microRNAs in cancer treatment [ J ]. Jpn J Clin 0ncol,2013,43(6) :596-607.
  • 5Aktas Y, Yemisci M, Andrieux K, et al. Development and brain delivery of chitosan PEG na-noparticles funetionalized with the monoctonal antibody 0X26 [ J ]. Bioeonjug Chem, 2005,16(6) : 1503-1511.
  • 6Namiki Y, Namiki T, Yoshida H, et al. A novel magnetic crystal-lipid nanostructure for magnetically guided in vivo gene delivery [ J ]. Nat Nanotechnol, 2009,4 ( 9 ) : 598-606.
  • 7Cancer Genome Atlas Research Network. Comprehensive genomic characterization defines human glioblastoma genes and core pathways [ J ]. Nature, 2008,455 ( 7216 ) : 1061 - 1068.
  • 8Friedman HS, Bigner DD. Glioblastoma muhiforme and the epidermal growth factor receptor[ J]. N Engl J Med,2005, 353(19) :1997-1999.
  • 9Fan QW, Weiss WA. RNA interference against a glioma-de- rived alleleof EGFR induces blockade at G2M [ J ]. Onco- gene,2005,24(5) :829-837.
  • 10Dillin A. The specifics of small interfering RNA specificity [ J]. Proc Nat Acd Sci, 2003,100 ( 11 ) : 6289-6291.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部